Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
10
91%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(4)

Detailed Status

Completed4
unknown4
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
80.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

recruiting218%
completed436%
unknown436%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11